Variable | Severe or fatal (n=41) | Not severe or fatal (n=1038) | OR | 95% CI | P value |
Clinical | |||||
Age | |||||
<40 years | 4 | 215 | 0.41 | 0.15 to 1.17 | 0.1 |
40–70 years | 23 | 574 | 1.03 | 0.55 to 1.94 | 0.92 |
>70 years | 14 | 249 | 1.64 | 0.85 to 3.18 | 0.14 |
Sex | |||||
Male | 18 | 379 | 1.36 | 0.73 to 2.55 | 0.34 |
Female | 23 | 659 | Reference group | Reference group | |
Ethnicity | |||||
Afro-Caribbean | 27 | 445 | 2.57 | 1.33 to 4.96 | 0.005 |
African American | 9 | 373 | 0.5 | 0.24 to 1.06 | 0.07 |
White | 2 | 41 | 1.25 | 0.29 to 5.34 | 0.77 |
Other | 4 | 172 | 0.54 | 0.19 to 1.55 | 0.25 |
ASA grade | |||||
I | 0 | 19 | Reference group | Reference group | |
II | 8 | 322 | 0.5 | 0.23 to 1.11 | 0.09 |
III | 17 | 465 | 0.81 | 0.43 to 1.54 | 0.51 |
IV and V | 14 | 144 | 3.13 | 1.59 to 6.17 | 0.001 |
Obesity | 17 | 349 | 1.4 | 0.74 to 2.64 | 0.3 |
Suspected or known duct stone | 37 | 811 | 2.59 | 0.91 to 7.34 | 0.07 |
Procedural | |||||
ASGE complexity grade | |||||
1 | 6 | 162 | 1.03 | 0.42 to 2.54 | 0.94 |
2 | 22 | 543 | 1.37 | 0.66 to 2.86 | 0.4 |
3 | 4 | 170 | 0.6 | 0.21 to 1.74 | 0.35 |
4 | 1 | 40 | 0.68 | 0.09 to 5.13 | 0.71 |
HOUSE complexity score | 38 | 993 | |||
1 | 27 | 751 | 0.79 | 0.39 to 1.62 | 0.52 |
2 | 9 | 165 | 1.56 | 0.72 to 3.35 | 0.26 |
3 | 2 | 77 | 0.66 | 0.16 to 2.79 | 0.57 |
Biliary stone extraction | 15 | 527 | 0.56 | 0.29 to 1.07 | 0.08 |
Antibiotics preprocedure | 23 | 440 | 1.74 | 0.93 to 3.26 | 0.09 |
ERCP, endoscopic retrograde cholangiopancreatography.